These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1717849)

  • 21. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M; Dunkel AJ; Thiemann RL; Leibowitz J; Zijlstra M; Jaenisch R
    J Immunol; 1993 Jul; 151(1):266-76. PubMed ID: 8326128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lens-specific expression of a major histocompatibility complex class I molecule disrupts normal lens development and induces cataracts in transgenic mice.
    Martin WD; Egan RM; Stevens JL; Woodward JG
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1144-54. PubMed ID: 7537260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus.
    Chen H; McCarty DM; Bruce AT; Suzuki K; Suzuki K
    Gene Ther; 1998 Jan; 5(1):50-8. PubMed ID: 9536264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes.
    Freedman MS; Ruijs TC; Selin LK; Antel JP
    Ann Neurol; 1991 Dec; 30(6):794-800. PubMed ID: 1838679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of the myelin basic protein gene promoter studied in transgenic mice.
    Asipu A; Mellor AL; Blair GE
    Biochem Biophys Res Commun; 2001 Nov; 288(4):809-18. PubMed ID: 11688980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells.
    Suzumura A; Lavi E; Bhat S; Murasko D; Weiss SR; Silberberg DH
    J Immunol; 1988 Mar; 140(6):2068-72. PubMed ID: 2831279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity.
    Jensen NA; Pedersen KM; Celis JE; West MJ
    Oncogene; 1998 Apr; 16(16):2123-9. PubMed ID: 9572493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wonky mice and MBP promoter.
    Turnley AM; Morahan G; Bartlett P; Miller JF
    Nature; 1992 Feb; 355(6361):594. PubMed ID: 1371595
    [No Abstract]   [Full Text] [Related]  

  • 32. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.
    Harrington EP; Catenacci RB; Smith MD; Heo D; Miller CE; Meyers KR; Glatzer J; Bergles DE; Calabresi PA
    Elife; 2023 Apr; 12():. PubMed ID: 37057892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model for focal demyelination of the spinal dorsal columns of transgenic MBP-LacZ mice by phototargeted ablation of oligodendrocytes.
    Vanderluit JL; Bourque JA; Peterson AC; Tetzlaff W
    J Neurosci Res; 2000 Oct; 62(1):28-39. PubMed ID: 11002285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes.
    Chen SC; Leach MW; Chen Y; Cai XY; Sullivan L; Wiekowski M; Dovey-Hartman BJ; Zlotnik A; Lira SA
    J Immunol; 2002 Feb; 168(3):1009-17. PubMed ID: 11801633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein.
    Frauman AG; Chu P; Harrison LC
    Mol Cell Biol; 1993 Mar; 13(3):1554-64. PubMed ID: 8441397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A transgenic mouse model for inducible and reversible dysmyelination.
    Mathis C; Hindelang C; LeMeur M; Borrelli E
    J Neurosci; 2000 Oct; 20(20):7698-705. PubMed ID: 11027231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules.
    Lee SC; Raine CS
    J Neuroimmunol; 1989 Dec; 25(2-3):261-6. PubMed ID: 2479662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mouse model for central nervous system demyelination.
    Yoshioka T; Feigenbaum L; Jay G
    Mol Cell Biol; 1991 Nov; 11(11):5479-86. PubMed ID: 1717829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation of MHC class I gene expression in rat oligodendrocytes.
    Mavria G; Hall KT; Jones RA; Blair GE
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):155-61. PubMed ID: 9461504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection.
    Redwine JM; Buchmeier MJ; Evans CF
    Am J Pathol; 2001 Oct; 159(4):1219-24. PubMed ID: 11583948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.